Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Phathom Pharmaceuticals, Inc. Director's Dealing 2020

Jul 13, 2020

32407_dirs_2020-07-13_c714cebe-aace-4dca-b5ba-898c4bd5a894.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2020-07-13

Reporting Person: Branning Todd P. (Chief Financial Officer)

More from Phathom Pharmaceuticals, Inc.

Regulatory Filings 2026
Jun 23
Declaration of Voting Results & Voting Rights Announcements 2026
May 21
Interim / Quarterly Report 2026
Apr 30
Earnings Release 2026
Apr 30
Annual Report 2026
Apr 7
Proxy Solicitation & Information Statement 2026
Apr 7
Regulatory Filings 2026
Mar 27
Call Transcript 2026
Mar 11
Director's Dealing 2026
Mar 3
Call Transcript 2026
Mar 2
View all filings →